(MMM) 3M - NYSE

Sector: Industrials | Industry: Conglomerates | Exchange: NYSE (USA) | Market Cap: 82.528m USD | Total Return: 14.8% in 12m

Adhesives, Abrasives, Safety Equipment, Office Supplies, Medical Tapes
Total Rating 59
Safety 89
Buy Signal -0.32
Conglomerates
Industry Rotation: +4.2
Market Cap: 82.5B
Avg Turnover: 572M
Risk 3d forecast
Volatility25.0%
VaR 5th Pctl4.00%
VaR vs Median-2.97%
Reward TTM
Sharpe Ratio0.50
Rel. Str. IBD43.5
Rel. Str. Peer Group65
Character TTM
Beta0.855
Beta Downside0.677
Hurst Exponent0.498
Drawdowns 3y
Max DD22.87%
CAGR/Max DD1.23
CAGR/Mean DD4.54
EPS (Earnings per Share) EPS (Earnings per Share) of MMM over the last years for every Quarter: "2021-06": 2.59, "2021-09": 2.45, "2021-12": 2.31, "2022-03": 2.65, "2022-06": 2.48, "2022-09": 2.69, "2022-12": 2.28, "2023-03": 1.97, "2023-06": 2.17, "2023-09": 2.68, "2023-12": 2.42, "2024-03": 2.39, "2024-06": 1.93, "2024-09": 1.98, "2024-12": 1.68, "2025-03": 1.88, "2025-06": 2.16, "2025-09": 2.19, "2025-12": 1.07, "2026-03": 2.14,
EPS CAGR: -9.38%
EPS Trend: -87.0%
Last SUE: 0.50
Qual. Beats: 0
Revenue Revenue of MMM over the last years for every Quarter: 2021-06: 8950, 2021-09: 8942, 2021-12: 8612, 2022-03: 8829, 2022-06: 8702, 2022-09: 8619, 2022-12: 8079, 2023-03: 8031, 2023-06: 8325, 2023-09: 8312, 2023-12: 8013, 2024-03: 6016, 2024-06: 6255, 2024-09: 6294, 2024-12: 6010, 2025-03: 5954, 2025-06: 6344, 2025-09: 6517, 2025-12: 6133, 2026-03: 6030,
Rev. CAGR: -11.92%
Rev. Trend: -90.5%
Last SUE: 0.04
Qual. Beats: 0

Warnings

Choppy

Tailwinds

No distinct edge detected

Description: MMM 3M

3M Company (MMM) is a diversified global manufacturer operating across three primary segments: Safety and Industrial, Transportation and Electronics, and Consumer. The company’s portfolio includes specialized abrasives, structural adhesives, electronic assembly materials, and consumer household brands. Founded in 1902 and headquartered in Saint Paul, Minnesota, 3M utilizes a vast distribution network encompassing e-commerce, wholesalers, and direct sales to reach industrial and retail end-markets.

As an industrial conglomerate, 3M relies on a business model centered on material science innovation and cross-segment technology sharing to maintain competitive advantages. The company operates in a capital-intensive sector where research and development investment is critical for maintaining market share across highly regulated industries like automotive and electronics. Investors assessing these complex operational segments may find ValueRay useful for deeper fundamental analysis.

Headlines to Watch Out For
  • PFAS litigation settlements and environmental remediation costs impact long-term cash flow
  • Global manufacturing activity and industrial production levels dictate organic revenue growth
  • Healthcare business spin-off completion influences valuation multiples and capital allocation
  • Consumer spending trends and retail inventory levels affect segment operating margins
  • Raw material price volatility and supply chain efficiency drive manufacturing profitability
Piotroski VR-10 (Strict) 8.0
Net Income: 2.79b TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA 5.99 > 1.0
NWC/Revenue: 21.42% < 20% (prev 25.32%; Δ -3.89% < -1%)
CFO/TA 0.08 > 3% & CFO 2.96b > Net Income 2.79b
Net Debt (8.96b) to EBITDA (6.25b): 1.43 < 3
Current Ratio: 1.59 > 1.5 & < 3
Outstanding Shares: last quarter (532.8m) vs 12m ago -2.72% < -2%
Gross Margin: 39.51% > 18% (prev 40.82%; Δ -1.31% > 0.5%)
Asset Turnover: 66.39% > 50% (prev 61.36%; Δ 5.03% > 0%)
Interest Coverage Ratio: 5.43 > 6 (EBIT TTM 4.91b / Interest Expense TTM 903.0m)
Altman Z'' 5.48
A: 0.15 (Total Current Assets 14.4b - Total Current Liabilities 9.03b) / Total Assets 35.4b
B: 1.08 (Retained Earnings 38.2b / Total Assets 35.4b)
C: 0.13 (EBIT TTM 4.91b / Avg Total Assets 37.7b)
D: 0.10 (Book Value of Equity 3.26b / Total Liabilities 32.1b)
Altman-Z'' = 5.48 = AAA
Beneish M -2.96
DSRI: 1.05 (Receivables 3.75b/3.50b, Revenue 25.0b/24.5b)
GMI: 1.03 (GM 40.82% / 39.51%)
AQI: 0.97 (AQ_t 0.40 / AQ_t-1 0.41)
SGI: 1.02 (Revenue 25.0b / 24.5b)
TATA: -0.00 (NI 2.79b - CFO 2.96b) / TA 35.4b)
Beneish M = -2.96 (Cap -4..+1) = A
What is the price of MMM shares?

As of June 20, 2026, the stock is trading at USD 160.60 with a total of 6,934,500 shares traded.
Over the past week, the price has changed by +1.70%, over one month by +5.84%, over three months by +11.27% and over the past year by +14.80%.

Is MMM a buy, sell or hold?

3M has received a consensus analysts rating of 3.84. Therefore, it is recommended to buy MMM.

  • StrongBuy: 9
  • Buy: 2
  • Hold: 5
  • Sell: 2
  • StrongSell: 1

What are the forecasts/targets for the MMM price?
Analysts Target Price 171 6.5%
3M (MMM) - Fundamental Data Overview as of 17 June 2026
Market Cap USD = 82.5b (82.5b USD * 1.0 USD.USD)
P/E Trailing = 30.4875
P/E Forward = 18.4162
P/S = 3.2979
P/B = 25.2919
P/EG = 1.6746
Revenue TTM = 25.0b USD
EBIT TTM = 4.91b USD
EBITDA TTM = 6.25b USD
Long Term Debt = 10.9b USD (from longTermDebt, last quarter)
Short Term Debt = 1.65b USD (from shortTermDebt, last quarter)
Debt = 13.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 553.0m
Net Debt = 8.96b USD (calculated: Debt 13.1b - CCE 4.15b)
Enterprise Value = 91.5b USD (82.5b + Debt 13.1b - CCE 4.15b)
Interest Coverage Ratio = 5.43 (Ebit TTM 4.91b / Interest Expense TTM 903.0m)
EV/FCF = 44.41x (Enterprise Value 91.5b / FCF TTM 2.06b)
FCF Yield = 2.25% (FCF TTM 2.06b / Enterprise Value 91.5b)
FCF Margin = 8.23% (FCF TTM 2.06b / Revenue TTM 25.0b)
Net Margin = 11.14% (Net Income TTM 2.79b / Revenue TTM 25.0b)
Gross Margin = 39.51% ((Revenue TTM 25.0b - Cost of Revenue TTM 15.1b) / Revenue TTM)
Gross Margin QoQ = 40.73% (prev 33.56%)
Tobins Q-Ratio = 2.58 (Enterprise Value 91.5b / Total Assets 35.4b)
Interest Expense / Debt = 6.89% (Interest Expense 903.0m / Debt 13.1b)
Taxrate = 25.54% (959.0m / 3.75b)
NOPAT = 3.65b (EBIT 4.91b * (1 - 25.54%))
Current Ratio = 1.59 (Total Current Assets 14.4b / Total Current Liabilities 9.03b)
Debt / Equity = 4.02 (Debt 13.1b / totalStockholderEquity, last quarter 3.26b)
Debt / EBITDA = 1.43 (Net Debt 8.96b / EBITDA 6.25b)
Debt / FCF = 4.35 (Net Debt 8.96b / FCF TTM 2.06b)
Total Stockholder Equity = 4.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.39% (Net Income 2.79b / Total Assets 35.4b)
RoE = 66.03% (Net Income TTM 2.79b / Total Stockholder Equity 4.22b)
RoCE = 32.43% (EBIT 4.91b / Capital Employed (Equity 4.22b + L.T.Debt 10.9b))
RoIC = 13.63% (NOPAT 3.65b / Invested Capital 26.8b)
WACC = 8.46% (E(82.5b)/V(95.6b) * Re(8.99%) + D(13.1b)/V(95.6b) * Rd(6.89%) * (1-Tc(0.26)))
Discount Rate = 8.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -1.83%
[DCF] Terminal Value 75.05% ; FCFF base≈2.06b ; Y1≈2.07b ; Y5≈2.19b
[DCF] Fair Price = 46.95 (EV 33.4b - Net Debt 8.96b = Equity 24.5b / Shares 521.6m; r=8.46% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: -87.00 | EPS CAGR: -9.38% | SUE: 0.50 | # QB: 0
Revenue Correlation: -90.51 | Revenue CAGR: -11.92% | SUE: 0.04 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.23 | Chg30d=+0.08% | Revisions=-57% | Analysts=14
EPS next Quarter (2026-09-30): EPS=2.35 | Chg30d=+0.21% | Revisions=-38% | Analysts=14
EPS current Year (2026-12-31): EPS=8.69 | Chg30d=-0.04% | Revisions=+25% | GrowthEPS=+7.9% | GrowthRev=+3.4%
EPS next Year (2027-12-31): EPS=9.47 | Chg30d=+0.11% | Revisions=+47% | GrowthEPS=+8.9% | GrowthRev=+3.4%
[Analyst] Revisions Ratio: -57%